RA Chem Pharma Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: RA Chem Pharma Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $2.6M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

RA Chem Pharma Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $2.6M Trade | TransData Nexus

RA Chem Pharma Limited

Indian Pharmaceutical Exporter · Cardiovascular Specialist · $2.6M Total Trade · DGFT Verified

RA Chem Pharma Limited is an Indian pharmaceutical exporter with a total trade value of $2.6M across 3 products in 3 therapeutic categories. Based on 54 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Isosorbide ($1.4M), Itraconazole ($1.1M), Tetracycline ($221.8K).

RA Chem Pharma Limited — Export Portfolio & Destination Treemap

RA Chem Pharma Limited pharmaceutical export portfolio — 3 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is RA Chem Pharma Limited? — Company Overview & Market Position

RA Chem Pharma Limited, established on January 8, 1996, is a publicly held Indian pharmaceutical company headquartered in Hyderabad, Andhra Pradesh. The company is registered under the Corporate Identification Number (CIN) U24110TG1996PLC022816. As of the latest available data, RA Chem Pharma has an authorized capital of ₹140 crore and a paid-up capital of ₹85.01 crore, reflecting a paid-up capital percentage of approximately 60.72%. The company operates in the manufacturing sector, focusing on chemicals and chemical products. RA Chem Pharma Limited is not listed on any stock exchange.

Over the past 15 years, RA Chem Pharma has expanded its operations by establishing fully cGMP-compliant manufacturing facilities, state-of-the-art research and development (R&D) centers, and a clinical research facility. The company's product portfolio includes active pharmaceutical ingredients (APIs), solid dosage formulations, and clinical studies, catering to various therapeutic categories.

What Does RA Chem Pharma Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Isosorbide$1.4M 2

Product Portfolio — Top 3 by Export Value

RA Chem Pharma Limited exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Isosorbide	Cardiovascular	$1.4M	27	3.0%	4
2	Itraconazole	Antifungals	$1.1M	21	3.8%	8
3	Tetracycline	Antibiotics	$221.8K	6	1.3%	15

RA Chem Pharma Limited exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $2.6M. The top category is Cardiovascular (51.5% of portfolio), followed by Antifungals (40.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

RA Chem Pharma Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

RA Chem Pharma Limited operates multiple manufacturing facilities across India. The company has a cGMP-compliant API manufacturing plant located in Jaggayapet, Krishna District, Andhra Pradesh. Additionally, it has a cGMP-compliant solid dosage formulation manufacturing facility at Nacharam, Hyderabad, and a GCP and GLP-compliant clinical research and biosciences division at Balanagar, Hyderabad.

3Key Leadership

The leadership team at RA Chem Pharma Limited comprises several key executives. Rajender Rao Juvvadi serves as a director, while Pritam Amir Singh, Ravula Sirish Kumar, Ravi Kumar Yerra, and Srinivasa Reddy Battula also hold directorial positions. The company's leadership is known for its visionary approach, technological competence, and commitment to research innovation.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does RA Chem Pharma Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

RA Chem Pharma Limited has made significant strides in obtaining regulatory approvals for its products in various international markets. The company's manufacturing facilities hold international accreditations, including those from the US FDA, EDQM, ANSM (France), WHO (Geneva), TGA (Australia), and MFDS (Korea). These certifications enable RA Chem Pharma to export its products to regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan. The company's adherence to Good Manufacturing Practices (GMP) and other regulatory standards ensures the quality and safety of its pharmaceutical products in these markets.

2Emerging Markets

RA Chem Pharma Limited has expanded its presence in emerging markets, including regions in Africa, Latin America, Southeast Asia, and South Asia. The company's international accreditations, such as those from the WHO (Geneva), facilitate access to these markets. By leveraging its manufacturing capabilities and regulatory compliance, RA Chem Pharma aims to meet the growing demand for quality pharmaceutical products in these regions.

3Geographic Strategy

RA Chem Pharma Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

RA Chem Pharma Limited's manufacturing facilities are registered with the US Food and Drug Administration (FDA), indicating compliance with FDA regulations. The company has filed Drug Master Files (DMFs) for over 50 APIs across diverse therapeutic categories, including antifungals, antipsychotics, NSAIDs, anti-allergy agents, antiparkinsons, anticonvulsants, antidepressants, antispasmodics, and animal feed additives. This extensive filing demonstrates RA Chem Pharma's commitment to meeting the stringent requirements of the FDA and underscores its capability to supply quality pharmaceutical products to the US market.

2WHO & EU GMP

RA Chem Pharma Limited's manufacturing facilities hold certifications from the World Health Organization (WHO) and the European Directorate for the Quality of Medicines & HealthCare (EDQM). These certifications attest to the company's adherence to international Good Manufacturing Practices (GMP) standards. The WHO prequalification and EU GMP certificates enable RA Chem Pharma to supply pharmaceutical products to international markets, including those in Europe and other regions that recognize these certifications.

3CDSCO & Indian Regulatory

RA Chem Pharma Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

RA Chem Pharma Limited operates in a competitive pharmaceutical industry, facing competition from both domestic and international companies. Its focus on manufacturing APIs and solid dosage formulations, along with its international accreditations, positions it favorably in the market. The company's commitment to quality, regulatory compliance, and customer support enhances its competitive edge. However, the pharmaceutical industry is dynamic, and RA Chem Pharma must continuously innovate and adapt to maintain its market position.

2Key Differentiators

RA Chem Pharma Limited's key differentiators include its vertically integrated operations, encompassing API manufacturing, solid dosage formulations, and clinical research. The company's state-of-the-art manufacturing facilities and dedicated R&D infrastructure support its ability to develop and manufacture a diverse range of pharmaceutical products. International accreditations from regulatory bodies such as the US FDA, EDQM, ANSM (France), WHO (Geneva), TGA (Australia), and MFDS (Korea) underscore the company's commitment to quality and regulatory compliance.

3Strategic Position

Buyer Due Diligence Brief — Evaluating RA Chem Pharma Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

RA Chem Pharma Limited has demonstrated a strong track record in pharmaceutical manufacturing, with a diverse product portfolio and a commitment to quality. The company's export volume and consistency are supported by its international accreditations and compliance with global regulatory standards. Reliability indicators include its adherence to cGMP, GCP, and GLP standards, as well as its history of successful regulatory approvals. These factors contribute to RA Chem Pharma's reputation as a dependable supplier in the pharmaceutical industry.

2Certifications to Verify

Importers should verify the following certifications when considering RA Chem Pharma Limited as a supplier:

FDA Registration: Confirm the company's registration status with the US FDA to ensure compliance with US regulations.

WHO-GMP Certification: Verify the WHO Good Manufacturing Practices certification to ensure adherence to international quality standards.

Frequently Asked Questions — RA Chem Pharma Limited

How many pharmaceutical products does RA Chem Pharma Limited export from India?

RA Chem Pharma Limited exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Isosorbide ($1.4M), Itraconazole ($1.1M), Tetracycline ($221.8K). Total export value is $2.6M.

What is RA Chem Pharma Limited's total pharmaceutical export value?

RA Chem Pharma Limited's total pharmaceutical export value is $2.6M, based on 54 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does RA Chem Pharma Limited cover?

RA Chem Pharma Limited exports across 3 therapeutic categories. The largest are Cardiovascular (51.5%, 1 products), Antifungals (40.0%, 1 products), Antibiotics (8.5%, 1 products).

Get Full RA Chem Pharma Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.